David R. Ebsworth
Director · Verona Pharma plc
Individual
- 2024
- Oct 7, 2025
- 6
Filings (90d)
Other insiders active in the same stocks
Insiders who have reported open-market trades at the same companies as David R. Ebsworth. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David Zaccardelli - $11.26M in VRNA purchases and sales on record
- Mark W. Hahn - $11.26M in VRNA purchases and sales on record
- Kathleen A. Rickard - $1.94M in VRNA purchases and sales on record
- Christina Ackermann - $222K in VRNA purchases and sales on record
- Michael Austwick - $148K in VRNA purchases and sales on record
- Martin Edwards - $142K in VRNA purchases and sales on record
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David R. Ebsworth?
David R. Ebsworth is a corporate insider, tracked as Director of Verona Pharma plc (VRNA). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did David R. Ebsworth last file a Form 4?
The most recent primary Form 4 on record is dated 7 October 2025, one of 6 filings going back to 2024.
Has David R. Ebsworth been buying or selling stock?
Recorded transactions: 2 open-market purchases ($278K) and 1 open-market sale ($25K) across all tracked filings.
